The NLRP3 inflammasome: contributions to inflammation-related diseases

Y Chen, X Ye, G Escames, W Lei, X Zhang, M Li… - Cellular & molecular …, 2023 - Springer
The NOD-like receptor protein 3 (NLRP3) inflammasome is a protein complex that regulates
innate immune responses by activating caspase-1 and the inflammatory cytokines …

Inflammasomes and atherosclerosis: a mixed picture

AR Tall, KE Bornfeldt - Circulation research, 2023 - Am Heart Assoc
The CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcome Study) and colchicine
trials suggest an important role of inflammasomes and their major product IL-1β (interleukin …

Prohibitin 1 regulates mtDNA release and downstream inflammatory responses

H Liu, H Fan, P He, H Zhuang, X Liu, M Chen… - The EMBO …, 2022 - embopress.org
Exposure of mitochondrial DNA (mtDNA) to the cytosol activates innate immune responses.
But the mechanisms by which mtDNA crosses the inner mitochondrial membrane are …

Clonal hematopoiesis and atherosclerosis

O Oren, AM Small, P Libby - The Journal of Clinical Investigation, 2024 - jci.org
Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a previously
unrecognized, potent, age-related, and common risk factor for atherosclerosis. Somatic …

Clonal hematopoiesis in cardiovascular disease and therapeutic implications

AR Tall, JJ Fuster - Nature cardiovascular research, 2022 - nature.com
Clonal hematopoiesis arises from somatic mutations that provide a fitness advantage to
hematopoietic stem cells and the outgrowth of clones of blood cells. Clonal hematopoiesis …

Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma

L Wang, D Wang, L Yang, X Zeng, Q Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Nasopharyngeal carcinoma (NPC) is the most common subcategory of head
and neck squamous cell carcinoma (HNSCC). This study focused on the roles of cuproptosis …

NLRP3 inflammasome in hepatic diseases: A pharmacological target

E Ramos-Tovar, P Muriel - Biochemical Pharmacology, 2023 - Elsevier
The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome pathway is
mainly responsible for the activation and release of a cascade of proinflammatory mediators …

Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke

X Zhang, W Zeng, Y Zhang, Q Yu… - International …, 2022 - spandidos-publications.com
Post‑ischemic neuroinflammation induced by the innate local immune response is a major
pathophysiological feature of cerebral ischemic stroke, which remains the leading cause of …

BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis

M Yalcinkaya, W Liu, LA Thomas, M Olszewska… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Clonal hematopoiesis (CH) has emerged as an independent risk factor for
atherosclerotic cardiovascular disease, with activation of macrophage inflammasomes as a …

Spirodalesol analog 8A inhibits NLRP3 inflammasome activation and attenuates inflammatory disease by directly targeting adaptor protein ASC

W Liu, J Yang, S Fang, C Jiao, J Gao, A Zhang… - Journal of Biological …, 2022 - ASBMB
Pharmacological inhibition of the Nod-like receptor family protein 3 (NLRP3) inflammasome
contributes to the treatment of numerous inflammation-related diseases, making it a …